Default: Journal of Acquired Immune Deficiency Syndromes

ISSN: 1525-4135

Journal Home

Journal Guideline

Journal of Acquired Immune Deficiency Syndromes Q1 Unclaimed

Lippincott Williams and Wilkins Ltd. United States
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Journal of Acquired Immune Deficiency Syndromes is a journal indexed in SJR in Infectious Diseases and Pharmacology (medical) with an H index of 157. It has an SJR impact factor of 2,162 and it has a best quartile of Q1. It has an SJR impact factor of 2,162.

Journal of Acquired Immune Deficiency Syndromes focuses its scope in these topics and keywords: hiv, health, viral, infant, expression, women, antiretroviral, therapy, cd, public, ...

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Price

- €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

Journal of Acquired Immune Deficiency Syndromes

2,162

SJR Impact factor

157

H Index

288

Total Docs (Last Year)

1036

Total Docs (3 years)

1690

Total Refs

3188

Total Cites (3 years)

930

Citable Docs (3 years)

2,78

Cites/Doc (2 years)

5,87

Ref/Doc

Aims and Scope


hiv, health, viral, infant, expression, women, antiretroviral, therapy, cd, public, voluntary, care, acid, prevention, load, risk, united, trial, testing, cell, circumcision, diagnosis, men, rakai, randomized, suppression, t, youth,



Best articles by citations

Health-Related Quality of Life After 1 Year of Highly Active Antiretroviral Therapy

View more

Higher Cystatin C Levels Are Associated With Neurocognitive Impairment in Older HIV+ Adults

View more

Implementation and Operational Research

View more

Clinical Utility of Resistance Testing: Retrospective and Prospective Data Supporting Use and Current Recommendations

View more

Effective Approaches for Programming to Reduce Adolescent Vulnerability to HIV Infection, HIV Risk, and HIV-Related Morbidity and Mortality

View more

Pediatric Treatment Scale-Up

View more

Addition of Single-Dose Tenofovir and Emtricitabine to Intrapartum Nevirapine to Reduce Perinatal HIV Transmission

View more

A Randomized, Open-Label Trial to Evaluate Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Plus Darunavir in Treatment-Experienced HIV-1-Infected Adults

View more

Addressing Poor Retention of Infants Exposed to HIV

View more

Comparison of Generic Zidovudine + Lamivudine (Cipla, Duovir) and the GlaxoSmithKline Brand (Combivir) Tablets

View more

ERRATUM

View more

Epidemiological Impact of Tenofovir Gel on the HIV Epidemic in South Africa

View more
SHOW MORE ARTICLES

Improved Quality of Life for Opioid-Dependent Patients Receiving Buprenorphine Treatment in HIV Clinics

View more

R211K and L214F Do Not Invariably Confer High Level Phenotypic Resistance to Thymidine Analogs in Zidovudine-Naive Patients With M184V

View more

Microsporidiosis and HIV

View more

Placental Membrane Inflammation and Risks of Maternal-to-Child Transmission of HIV-1 in Uganda

View more

Perception of HIV Risk and Adherence to a Daily, Investigational Pill for HIV Prevention in FEM-PrEP

View more

PrEP Implementation Behaviors of Community-Based HIV Testing Staff

View more

129 Human Endogenous Retrovirus-K (HML-2) Elements in the Plasma of People with Lymphoma and Breast Cancer

View more

PrEP4Love

View more

Prevalence and Route of Transmission of Infection With a Novel DNA Virus (TTV), Hepatitis C Virus, and Hepatitis G Virus in Patients Infected With HIV

View more

Rising Prevalence of HIV-1 Non-B Subtypes in Belgium: 1983???2001

View more

Course of Viral Load Throughout HIV-1 Infection

View more

Efavirenz Versus Nevirapine in Current Clinical Practice: A Prospective, Open-Label Observational Study

View more

Comments

No comments ... Be the first to comment!

FAQS